Abstract
Background
Patient-orientated endpoints have attracted little attention in patients with malignant choroidal melanoma. This study was conducted to explore the long-term effects of malignant choroidal melanoma and radiotherapy on QOL by means of a differentiated and modular QOL approach, including global QOL, social support, and mental health, in comparison with sociodemographically matched healthy controls.
Methods
A random sample of 100 outpatients treated by radiotherapy were asked by mail to take part in a psychodiagnostic study [instruments: Short-Form 36 Health-Survey (SF-36), Symptom Checklist-90-Revised, German Social Support Questionnaire]. The same instruments were applied to a healthy control group, which was matched to patients with regard to age, gender, and vocational situation.
Results
93 patients (average age 61.2 years) responded at an average of 5.5 years (±3.7) after diagnosis. Visual acuity in the affected eye decreased considerably from diagnosis (0.49±0.30) to participation in the study (0.09±0.21). Compared with healthy controls, patients reported on average statistically significantly lower global QOL (SF-36), whereas social support and mental distress did not differ. Frequencies of clinically relevant mental distress were significantly higher in patients than in controls (35.5% vs. 16.1%). Mental distress was associated with poorer visual acuity, but not with the extent of loss of visual acuity or number of follow-up treatments.
Conclusion
Patients with choroidal melanoma suffer from low long-term global QOL, and every third patient suffers from relevant mental distress. Regular screening for mental distress should be implemented along with psychological counseling. Additional follow-up treatment does not seem to induce mental distress.
Similar content being viewed by others
References
American Society of Clinical Oncology (1996) Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. J Clin Oncol 14:671–679
Brandberg Y, Kock E, Iskar K, Af Trampe E, Seregard S (2000) Psychological reactions and quality of life in patients with posterior uveal melanoma treated with ruthenium plaque therapy or enucleation: a one year follow-up study. Eye 14:839–846
Bullinger M, Kirchberger I (1998) SF-36. Fragebogen zum Gesundheitszustand. Hogrefe, Goettingen
Cassileth BR, Lusk EJ, Strouse EJ, Miller DS, Brown LL, Cross PA, Tenaglia AN (1984) Psychosocial status in chronic illness: a comparative analysis of six diagnosis groups. N Engl J Med 311:506–511
Collaborative Ocular Melanoma Study Group (2001) Collaborative Ocular Melanoma Study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years. COMS report No. 16. Ophthalmology 108:348–366
Collaborative Ocular Melanoma Study Group (2001) The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma. III. Initial mortality findings. Arch Ophthalmol 119:969–982
Cruickshanks KJ, Fryback DG, Nondahl DM, Robinson N, Keesey U, Dalton DS, Robertson DM, Chandra SR, Mieler WF, Zakov ZN, Custer PL, DelPriore LV, Albert DM (1999) Treatment choice and quality of life in patients with choroidal melanoma. Arch Ophthalmol 117:461–467
Derogatis LR (1992) SCL-90-R, administration, scoring and procedures manual-II for the r(evised) version and other instruments of the psychopathology rating scale series. Clinical Psychometric Research Inc.,Townson
Derogatis LR, Morrow GR, Fetting J, Penman D, Piastsky S, Schmale AM, Henrichs M, Carnicke CLM (1983) The prevalence of psychiatric disorders among cancer patients. J Am Med Assoc 249:751–757
Fawzy FI (1999) Psychosocial interventions for patients with cancer: what works and what doesn't. Eur J Cancer 35:1559–1564
Federici TJ, Meyer DR, Lininger LL (1999) Correlation of the vision-related functional impairment associated with blepharoptosis and the impact of blepharoptosis surgery. Ophthalmology 106:1705–1712
Franke GH (1994) Testtheoretische Überprüfung des Fragebogens zur Sozialen Unterstützung. Z Med Psychol 4:168–177
Franke GH (2002) SCL-90-R. Die Symptom-Checkliste von Derogatis—Deutsche Version – Manual, 2. überarbeitete und neu normierte Auflage. Beltz-Testgesellschaft, Göttingen
Franke GH, Heemann U, Kohnle M, Luetkes P, Maehner N, Reimer J (2000) Quality of life in patients before and after kidney transplantation. Psychol Health 14:1037–1049
Franke GH, Esser J, Reimer J, Maehner N (2002) Vision-targeted quality of life under different degrees of visual impairment. Rev Port Psicossom 4:39–49
Fydrich T, Sommer G, Menzel U, Höll C (1987) Fragebogen zur sozialen Unterstützung (Kurzform; SOZU-K-22). Z Klin Psychol 16:434–436
Glasgow RE, Hampson SE (1995) Recruiting older subjects for psychological studies of chronic disease: are community volunteer and clinic-based samples equivalent? Psychol Health 10:245–254
Grassi L, Rosti G (1996) Psychosocial morbidity and adjustment to illness among long-term cancer survivors. A six-year follow-up study. Psychosomatics 37:523–532
Gutierrez P, Wilson MR, Johnson C, Gordon M, Cioffi GA, Ritch R, Sherwood M, Meng K, Mangione CM (1997) Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol 115:777–784
Hart PM, Chakravarthy U, Stevenson MR (1998) Questionnaire-based survey on the importance of quality of life measures in ophthalmologic practice. Eye 12:124–126
House JS, Landis KR, Umberson D (1988) Social relationship and health. Science 241:540–545
Klein R, Moss SE, Klein BEK, Gutierrez P, Mangione M (2001) The NEI-VFQ-25 in people with long-term type 1 diabetes mellitus. Arch Ophthalmol 119:733–740
Lee PP, Whitcup SM, Hays RD, Spritzer K, Javitt J (1995) The relationship between visuall acuity and functioning and well-being among diabetics. Qual Life Res 4:319–323
Lee PP, Spritzer K, Hays RD (1997) The impact of blurred vision on functioning and well-being. Ophthalmology 104:390–396
Mangione CM, Phillips RS, Lawrence MG, Seddon JM, Orav EJ, Goldman L (1994) Improved visual function and attenuation of declines in health-related quality of life after cataract extraction. Arch Ophthalmol 112:1419–1425
Mangione CM, Goldman L, Orav EJ, Marcantonio ER, Ludwig LE, Donaldson MC, Sugarbaker DJ, Poss R, Lee TH (1997) Health-related quality of life after elective surgery: measurement of longitudinal changes. J Gen Intern Med 12:686–697
Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD; for the NEI-VFQ Field Test Investigators (1998) Psychometric properties of the National Eye Visual Function Questionnaire (NEI-VFQ). Arch Ophthalmol 116:1496–1504
Mangione CM, Gutierrez PR, Lowe G, Orav EJ, Seddon JM (1999) Influence of age-related maculopathy on visual functioning and health-related quality of life. Am J Ophthalmol 128:45–53
National Research Committee on Vision (1980) Recommended standard procedures for the clinical measurement and specification of visual acuity. Adv Ophthalmol 41:103–8
Revicki DA, Osoba D, Fairclough D, Barofsky I, Berzon R, Leidy NK, Rothman M (2000) Recommendations on health related quality of life research to support labeling and promotional claims in the United States. Qual Life Res 9:887–900
Schueler AO, Bornfeld N (2000) Current therapy aspects of intraocular tumors. Ophthalmologe 97:207–222
Scott IU, Schein OD, West S, Bandeen-Roche K, Enger C, Folstein F (1994) Functional status and quality of life measurement among ophthalmic patients. Arch Ophthalmol 112:329–35
Shields CL, Shields JA, Cater J, Gündüz K, Miyamoto C, Micaily B, Brady LW (2000) Plaque radiotherapy for uveal melanoma. Long-term outcome in 1106 consecutive patients. Arch Ophthalmol 118:1219–1228
Simpson JSA, Carlson LE, Beck CA, Patten S (2002) Effects of a brief intervention on social support and psychiatric morbidity in breast cancer patients. Psycho-Oncology 11:282–294
Wachtlin J, Bechrakis NE, Schueler AO, Helbig H, Bornfeld N, Foerster MH (2000) Phacoemulsification following treatment of choroidal melanoma. Graefes Arch Clin Exp Ophthalmol 238:942–948
Wandell PE, Lundstrom M, Brorsson B, Aberg H (1997) Quality of life among patients with glaucoma in Sweden. Acta Ophthalmol Scand 75:584–8
Ware JE, Snow KK, Kosinski M, Gandek B (1993) SF-36 Health-survey manual and interpretation guide. Nimrod Press, Boston
Wilson MR, Coleman AL, Yu F, Sasaki IF, Berlin K, Winters J, Lai A (1998) Functional status and well-being in patients with glaucoma as measured by the Medical Outcomes Study Short Form-36 Health Survey. Ophthalmology 105:2112–2116
Wulsin LR, Jacobson AM, Rand LI (1991) Psychosocial correlates of mild visual loss. Psychosom Med 53:109–117
Zabora JR (1998) Screening procedures for psychosocial distress. In: Holland JC (ed) Psychooncology. Oxford University Press, New York, pp 653–661
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Reimer, J., Esser, J., Fleiss, A. et al. Quality of life in patients with malignant choroidal melanoma after radiotherapy. Graefe's Arch Clin Exp Ophthalmol 241, 371–377 (2003). https://doi.org/10.1007/s00417-003-0654-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-003-0654-4